If you are interested in the US market and looks for blessing in disguise counter and of cause if u hv USD$$ in plenty, below five companies make swine flu vaccine for the U.S. market:
1) AstraZeneca's
[AZN 46.16 -0.14 (-0.3%) ]
2) MedImmune unit, CSL
3) GlaxoSmithKline
[GSK 39.44 -0.59 (-1.47%) ]
4) Novartis
[NVS 45.30 -0.19 (-0.42%) ]
5) Sanofi-Aventis
[SNY 33.94 0.06 (+0.18%) ]
.
CSL and Sanofi have started U.S. trials and several companies, including Glaxo, have trials ongoing in Europe. The U.S. Food and Drug Administration will license the new vaccine as a "strain change" from seasonal influenza — treating it as the usual annual reformulation of the annual flu vaccine.
Pandemic H1N1 is circulating widely and experts expect it to get worse in the Northern Hemisphere's fall as schools get under way. The council's report says the virus, although moderate, poses a serious health threat to the United States because it is likely to infect so many people.
(source : CNBC)
...
No comments:
Post a Comment